| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 1996;27:134-139.)
© 1996 American Heart Association, Inc.
Articles |
From the Department of Anatomy and Cell Biology, East Carolina University, Medical School, Greenville (T.M.L.), and the Departments of Physiology and Pharmacology (W.M., D.W.B.) and Pediatrics (R.A.E.), Bowman Gray School of Medicine, Wake Forest University, Winston-Salem, NC; and the Department of Physiology, Albert Szent-Györgyi Medical University, Szeged, Hungary (F.B.).
Correspondence to Thomas M. Louis, PhD, Department of Anatomy and Cell Biology, East Carolina University, Medical School, Greenville, NC 27858.
| Abstract |
|---|
|
|
|---|
Methods Piglets were anesthetized and ventilated with a respirator. Pial arteriolar diameter was determined using a closed cranial window and intravital microscopy. Baseline arteriolar diameters ranged from 80 to 100 µm. Arteriolar responses to 10-9 and 10-8 mmol/L CGRP applied topically were determined before and 1, 2, and 4 hours after a 10-minute period of total global ischemia. Ischemia was caused by increasing intracranial pressure.
Results Before ischemia, CGRP dilated arterioles by 14±2% (n=6) and 24±3% (n=7) at 10-9 and 10-8 mmol/L, respectively. However, after ischemia, arteriolar responses to 10-9 mmol/L CGRP were reduced at 1 hour to 4±1%, at 2 hours to 3±2%, and at 4 hours to 5±4% (P<.05 for all comparisons). Similarly, arteriolar responses to 10-8 mmol/L CGRP were reduced to 5±2% at 1 hour, 5±2% at 2 hours, and 10±6% at 4 hours (P<.05 for all comparisons). In time control animals, arteriolar responses to CGRP did not change over time. In other animals, we examined effects of pretreatment with indomethacin (5 mg/kg IV) on ischemia-induced decreases in arteriolar responses to CGRP. Indomethacin administration did not preserve arteriolar dilation to CGRP at 1 hour after ischemia, but responses were normal at 2 hours.
Conclusions Total global ischemia leads to prolonged attenuated dilator responses of cerebral arterioles to CGRP. In addition, indomethacin treatment alters effects of ischemia on CGRP-induced dilation.
Key Words: cerebral arteries indomethacin oxygen radical prostaglandins vasodilation pigs
| Introduction |
|---|
|
|
|---|
Because CGRP is one of the most potent cerebral vasodilators in humans13 as well as animals,1 2 3 6 this peptide has become a potential candidate for use as a therapeutic agent. Recently, pretreatment with intravenous CGRP before insult has been shown to limit the extent of brain damage after focal cerebral ischemia.14 Although exact mechanisms are unclear, it seems likely that protective actions of CGRP involve cerebral vasodilation. For CGRP to be useful clinically against cerebral ischemia, it must be effective if given after the onset of ischemia or other pathological conditions such as subarachnoid hemorrhage.15 However, cerebral vascular responses to exogenous CGRP after ischemia have not been examined. Cerebral vascular responsiveness may be altered, since anoxic stress has been shown to downregulate ATP-sensitive K+ channels16 and eliminate or attenuate NO-dependent responses.17 18
The purpose of this study was to investigate the effects of ischemia on dilator responses of cerebral arterioles to topically applied CGRP. We tested the hypothesis that the ability of CGRP to dilate cerebral arterioles would be reduced when CGRP is administered after ischemia. Furthermore, we investigated the role of cyclooxygenase-derived radicals in altered cerebral vascular responses to CGRP. Arteriolar dilation to CGRP has been shown to be eliminated by agents that generate oxygen radicals.19 The primary source of oxygen radicals in piglet cortex with ischemia-reperfusion is via the cyclooxygenase pathway, and superoxide anion production is blocked by indomethacin pretreatment.20 By itself, indomethacin administration does not alter cerebrovascular responses to CGRP.1
| Materials and Methods |
|---|
|
|
|---|
-chloralose (75 mg/kg IV).
-Chloralose was administered as
needed to maintain a stable level of anesthesia. The
piglets were intubated and artificially ventilated. A femoral artery
and vein were cannulated with PE-90 tubing. Arterial blood
samples were taken regularly from the femoral artery to measure blood
gases and pH. Levels of arterial blood pressure, gases, and
pH were maintained within the normal physiological
range. Each piglet's head was fixed in a stereotaxic
apparatus, the scalp was cut, and the connective tissue
over the parietal bone was removed. A craniectomy (19 mm in diameter)
was made in the parietal bone. The dura was cut and reflected over the
skull. A stainless steel and glass cranial window with three ports was
put into the opening, sealed with bone wax, and cemented with superglue
followed by two layers of dental acrylic. The closed window was filled
with artificial cerebrospinal fluid (aCSF) that was warmed to 37°C
and equilibrated with 6% O2 and 6.5% O2 in
N2.
Cerebral Ischemia-Reperfusion Injury
Cerebral
ischemia-reperfusion injury20
was produced using a hollow brass bolt implanted in the right parietal
cranium 20 mm rostral to the cranial window. Immediately after
placement of the cranial window, we drilled a hole in the skull with an
electric drill with a toothless bit. A circular (diameter, 3 mm) piece
of skull was removed without damaging the dura. The bolt was secured
with superglue and dental acrylic. The hollow bolt allowed infusion of
aCSF into the cranium to increase intracranial pressure, producing
ischemia. After implantation of the window and the bolt, aCSF
was allowed to equilibrate with the periarachnoid fluid under the
window for 20 minutes. To induce total cerebral ischemia, aCSF
was infused to maintain intracranial pressure approximately 15 mm Hg
above mean arterial pressure. Venous blood was withdrawn as
necessary to maintain mean arterial pressure near normal.
This procedure results in a complete reduction of blood flow through
the cortex. At the end of the 10-minute ischemia period, the
infusion tube was clamped, and the intracranial pressure was allowed to
return to atmospheric pressure.
The arterioles on the cerebral surface were observed under a microscope (Wild M36) equipped with a television camera (Panasonic) and a monitor (Panasonic). The diameter of the blood column in the arteriole was measured perpendicularly on the monitor with a video microscaler (IV-550, For-A Co).
Experimental Design
At the beginning of each experiment, the
cranial window was
flushed with aCSF several times, and arteriolar responses to CGRP
(10-9 and
10-8 mmol/L) were determined. Then,
piglets were divided into either sham or ischemia groups. In
the sham group, the bolt was implanted but intracranial pressure was
not increased. In the ischemia group, intracranial pressure was
increased for 10 minutes. During the ischemic period, there was
no blood flow through the pial vessels. In sham or ischemic
animals, arteriolar responses to CGRP were tested at 1, 2, and 4
hours.
To assess the role of ATP-sensitive K+ channels in CGRP-induced vasodilation, we determined arteriolar responses to CGRP in the absence and presence of glibenclamide (10-5 mmol/L) in another set of animals. Glibenclamide is an inhibitor of ATP-sensitive K+ channels.21 We have shown previously that this dose of glibenclamide is able to completely block arteriolar dilation to 10-8 and 10-6 mmol/L aprikalim (a specific inhibitor of ATP-sensitive K+ channels) but not to alter arteriolar responsiveness to severe arterial hypercapnia.22
In another set of animals, we also examined the role of cyclooxygenase-derived radicals in altered responses to CGRP. Before ischemia, arteriolar responses to CGRP (10-9, 10-8, and 10-7 mmol/L) were determined. Then, indomethacin (5 mg/kg IV) was given 20 minutes before ischemia. We have shown that superoxide anion production in piglet cortex during reperfusion is due to metabolism of arachidonic acid by cyclooxygenase and that this dose of indomethacin blocks superoxide anion production.20 At 1 hour and 2 hours after 10 minutes of ischemia, arteriolar responses to CGRP were again determined.
Statistical Analysis
All values are expressed as
mean±SEM. Where appropriate, data
were analyzed with the paired t test or
repeated-measures ANOVA. When the F value was significant, pairwise
comparisons were made with the Student-Newman-Keuls test. A value of
P<.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
|
Administration of glibenclamide did not alter resting arteriolar
diameter (112±11 µm before and 110±12 µm with
glibenclamide;
n=4). Coadministration of glibenclamide reduced arteriolar dilation to
CGRP at both 10-8 and
10-7 mmol/L (Fig 3
).
|
Indomethacin pretreatment had minimal effects on
baseline arteriolar dilation. Arteriolar diameter was 95±3 µm
before
the first exposure to CGRP and was 92±9 µm after
indomethacin treatment and before ischemia.
Indomethacin given before ischemia failed to
preserve normal responsiveness to CGRP at 1 hour (Fig 4
). In
contrast to responses at 1 hour,
arteriolar responses to CGRP in
indomethacin-treated animals at 2 hours after
ischemia were not different from preischemia
responses (Fig 5
). Each of the animals that showed
normal responsiveness at 2 hours had shown reduced arteriolar
responsiveness to CGRP at 1 hour. For these five animals, arterioles
dilated at 1 hour by 4±1% at 10-9
mmol/L, 5±2% at 10-8 mmol/L, and
12±3% at 10-7 mmol/L (P<.05
compared with baseline for all comparisons).
|
|
| Discussion |
|---|
|
|
|---|
Cerebrovascular Effects of CGRP
CGRP is one of the most
potent dilator stimuli in the cerebral
circulation.1 2 3 6 13
Exogenous CGRP dilates pial
arterioles in a dose-dependent manner, and the mode of dilation, at
least in piglets, is independent of major effects of
prostaglandins and NO.1 Normal access of CGRP
to cerebrovascular smooth muscle is primarily via release from
perivascular sensory fibers, which originate from the ophthalmic branch
of the trigeminal nerve.4 5 Several studies indicate
that
CGRP exerts important dilator effects on cerebral resistance vessels
during a number of conditions. For example, cerebral arteriolar
dilation during cortical spreading depression is mediated in part by
endogenous release of CGRP.8 In addition, CGRP
appears to participate in cerebrovascular dilation during
arterial hypotension.9 Furthermore, trigeminal
ganglionectomy, which removes effects of CGRP as well as other peptides
such as substance P and neurokinin A from cerebral vessels, also
influences vascular tone during arterial hypertension,
seizure activity, and ischemia.10 11 12
Thus,
endogenous CGRP is an important factor to consider in
cerebral vascular control.
Role of ATP-Sensitive K+ Channels in CGRP
Responses
Several recent reports suggest that activation of
ATP-sensitive
K+ channels is an important mechanism of vasodilation in
cerebral as well as peripheral resistance vessels.
Selective agonists of ATP-sensitive K+ channels such as
aprikalim promote cerebral arteriolar dilation,23 24
and
arteriolar dilation is blocked by glibenclamide.24
Glibenclamide selectively inhibits the opening of ATP-gated
K+ channels.21 In addition, glibenclamide has
been shown to attenuate arteriolar dilation to CGRP. For example,
Kitazono et al6 have shown that glibenclamide inhibits the
dilatory response to CGRP by 70% and 40% at
10-9 and
10-8 mmol/L, respectively. In our
experiments, we showed that glibenclamide inhibited dilation to CGRP by
more than 80% at 10-8 mmol/L and by
approximately 60% at 10-7 mmol/L. Taken
together, these results indicate that activation of ATP-sensitive
K+ channels is a major component of CGRP-induced cerebral
vascular dilation. The remaining vasodilation, especially at higher
doses of CGRP, may be mediated (depending on the species examined) by
other cyclic AMPdependent mechanisms not involving ATP-sensitive
K+ channels6 or perhaps by cyclic
GMPdependent mechanisms.6 7
Responses to CGRP After Ischemia
There have been few
systematic studies of cerebrovascular
responses to dilator neurotransmitters during the immediate
postischemic period. In general, arteriolar responses are
either transiently affected or not changed at all by ischemia.
For example, pial arteriolar dilation to isoproterenol25
and sodium nitroprusside26 is intact in piglets after
ischemia. On the other hand, arteriolar dilator responses to
N-methyl-D-aspartate17 26 in
piglets and acetylcholine18 in cats are reduced or
reversed, respectively, after anoxic stress, but normal responsiveness
returns within 2 to 4 hours. Both
N-methyl-D-aspartate and acetylcholine dilate
via mechanisms involving synthesis and actions of NO, and altered
vascular responsiveness is due to effects of oxygen
radicals.17 18 27 28 Our
present findings are unique
in that CGRP-induced dilation is almost completely eliminated for up to
4 hours after ischemia. Elimination of arteriolar dilation to
CGRP after ischemia may be due to factors such as dysfunction
or uncoupling of CGRP receptors, disruption of second-messenger
systems,19 decrease in numbers of ATP-sensitive
K+ channels,22 and/or inactivation of
ATP-sensitive K+ channels.16
Potential agents of vascular dysfunction to CGRP after ischemia could involve oxygen radicals such as superoxide anion. We have shown that superoxide anion is produced in large quantities in cerebral cortex after ischemia in piglets and that indomethacin pretreatment blocks superoxide anion production during these conditions.20 This latter finding is consistent with the view that oxygen radical production in cerebral cortex occurs predominantly via metabolism of arachidonic acid by cyclooxygenase.20 29 30 In the present study, we found that administration of indomethacin before ischemia was unable to preserve normal arteriolar responsiveness to CGRP at 1 hour but was able to restore dilation to preischemic values at 2 hours. These results are somewhat consistent with the findings of Kontos and Wei,19 who showed that oxygen radicals, possibly superoxide anion, were able to eliminate cerebral arteriolar dilation to CGRP.
Implications
There has been intense interest in the
development of therapeutic
agents that can improve outcome in patients with stroke, perhaps by
selectively dilating cerebral resistance vessels. CGRP, because of its
potent dilator effects, might be one such agent. Recently, Holland et
al14 showed that intravenous CGRP reduces
brain injury in a rat model of focal cerebral ischemia if given
before insult. However, for CGRP to be a truly useful therapeutic agent
in humans, it must be effective at times after the onset of cerebral
ischemia or stroke because it is at this time that patients
seek treatment. Our results indicate that CGRP has minimal arteriolar
dilator effects if given after only 10 minutes of ischemic
stress. It is possible that CGRP administration could dilate collateral
blood vessels in adjacent healthy brain after stroke and thus improve
blood flow to ischemic tissue. However, arterioles in the areas
directly affected by stroke may be minimally responsive to CGRP. In
addition, our results show that relatively large amounts of CGRP
applied to the brain surface before ischemia fail to preserve
arteriolar dilator responses for up to 4 hours after
ischemia.
Summary
Our findings indicate that 10 minutes of ischemic
stress
is sufficient to virtually eliminate cerebral arteriolar dilation to
CGRP for up to 4 hours. The mechanism of impaired CGRP-induced
vasodilation is unclear but could involve effects of oxygen radicals.
Possible sites of dysfunction could be at the level of CGRP receptors,
second-messenger systems, or ATP-sensitive K+ channels
in cerebral vascular smooth muscle.
| Acknowledgments |
|---|
Received August 30, 1995; revision received October 13, 1995; accepted October 13, 1995.
| References |
|---|
|
|
|---|
2. Edvinsson L, Fredholm BB, Hamel E, Jansen I, Verrecchia C. Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett. 1985;58:213-217. [Medline] [Order article via Infotrieve]
3.
Edwards RM, Stack EJ, Trizna W. Calcitonin
gene-related peptide stimulates adenylate cyclase and
relaxes intracerebral arterioles. J
Pharmacol Exp Ther. 1991;257:1020-1024.
4. Saito K, Greenberg S, Moskowitz MA. Trigeminal origin of beta-preprotachykinin products in feline pial blood vessels. Neurosci Lett. 1987;76:69-73. [Medline] [Order article via Infotrieve]
5. Uddman R, Edvinsson L, Ekman R, Kingman R, McCulloch J. Innervation of the feline cerebral vasculature by nerve fibres containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett. 1985;62:131-136. [Medline] [Order article via Infotrieve]
6.
Kitazono T, Heistad DD, Faraci FM. Role of
ATP-sensitive K+ channels in CGRP-induced dilatation of
basilar artery in vivo. Am J Physiol. 1993;265:H581-H585.
7.
Wei EP, Moskowitz MA, Boccalini P, Kontos HA.
Calcitonin generelated peptide mediates
nitroglycerin and sodium nitroprussideinduced
vasodilation in feline cerebral arterioles.
Circ Res. 1992;70:1313-1319.
8.
Colonna DM, Meng W, Deal DD, Busija DW.
Calcitonin gene-related peptide promotes cerebrovascular dilation
during cortical spreading depression in rabbits. Am J
Physiol. 1994;266:H1095-H1102.
9.
Hong DW, Pyo KM, Lee WS, Yu SS, Rhim BY.
Pharmacological evidence that calcitonin gene-related peptide is
implicated in cerebral autoregulation. Am J Physiol. 1994;266:H11-H16.
10.
Moskowitz MA, Wei EP, Sito K, Kontos HA.
Trigeminalectomy modifies pial arteriolar responses to hypertension and
noradrenaline. Am J Physiol. 1988;255:H1-H6.
11.
Sakas DE, Moskowitz MA, Wei EP, Kontos HA, Kano M,
Ogilvy CS. Trigeminovascular fibers increase blood flow in
cortical grey matter by axon-like mechanisms during acute severe
hypertension or seizures. Proc Natl Acad Sci
U S A. 1989;86:1401-1405.
12.
Moskowitz MA, Sakas DE, Kano EP, Buzzi MG, Ogilvy C,
Kontos HA. Postocclusive cerebral hyperaemia is markedly
attenuated by chronic trigeminal ganglionectomy. Am J
Physiol. 1989;257:H1736-H1739.
13. Jansen I, Mortensen A, Edvinsson L. Characterization of calcitonin gene-related peptide receptors in human cerebral vessels: vasomotor responses and cAMP accumulation. Ann N Y Acad Sci. 1992;657:435-440. [Medline] [Order article via Infotrieve]
14. Holland JP, Sydserff SGC, Taylor WAS, Bell BA. Calcitonin gene-related peptide reduces brain injury in a rat model of focal cerebral ischemia. Stroke. 1994;25:2055-2059. [Abstract]
15. Juul R, Askhus S, Bjornstad K, Gisvold SE, Brubakk AO, Edvinsson L. Calcitonin gene-related peptide counteracts vasoconstriction in human subarachnoid haemorrhage. Neurosci Lett. 1994;170:67-70. [Medline] [Order article via Infotrieve]
16. Mourre C, Smith M-L, Siesjö BK, Lazdunski M. Brain ischemia alters the density of binding sites for glibenclamide, a specific blocker of ATP-sensitive K+ channels. Brain Res. 1990;526:147-152. [Medline] [Order article via Infotrieve]
17. Busija DW, Meng W. Altered cerebrovascular responsiveness to N-methyl-D-aspartate after asphyxia in piglets. Am J Physiol. 1992;265:H389-H394.
18.
Nelson CW, Wei EP, Povlishock JT, Kontos HA, Moskowitz
MA. Oxygen radicals in cerebral ischemia.
Am J Physiol. 1992;263:H1356-H1362.
19.
Kontos HA, Wei EP. Hydroxyl
radicaldependent inactivation of guanylate cyclase in
cerebral arterioles by methylene blue and by LY 83583.
Stroke. 1993;24:427-434.
20.
Armstead W, Mirro R, Busija DW, Leffler CW.
Postischemic generation of superoxide anion by newborn pig
brain. Am J Physiol. 1988;255:H401-H403.
21.
Nelson MT, Patlak JB, Worley JF, Standen NB.
Calcium channels, potassium channels, and voltage dependence of
arterial smooth muscle tone. Am J
Physiol. 1990;259:C3-C8.
22. Busija DW, Louis TM. Ischemia alters cerebrovascular K+ channel function in piglets. Soc Neurosci. 1995;21:1671. Abstract.
23.
Masuzawa K, Asano M, Matsuda T, Imaizumi Y, Watanabe
M. Possible involvement of ATP-sensitive K+ channels
in the relaxant response of dog middle cerebral artery to
cromakalim. J Pharmacol Exp Ther. 1990;255:818-825.
24.
Faraci FM, Heistad DD. Role of ATP-sensitive
potassium channels in the basilar artery. Am J
Physiol. 1993;264:H8-H13.
25.
Leffler CW, Beasley DG, Busija DW. Cerebral
ischemia alters cerebral microvascular reactivity in newborn
pigs. Am J Physiol. 1989;257:H266-H271.
26. Busija DW, Meng W, Bari F, McGough S, Errico R, Tobin JR, Louis TM. Effects of ischemia on cerebrovascular responses to N-methyl-D-aspartate in piglets. Am J Physiol. 1995. In press.
27.
Faraci FM, Breese KR. Nitric oxide mediates
vasodilatation in response to activation of
N-methyl-D-aspartate receptors in brain.
Circ Res. 1993;72:476-480.
28.
Meng W, Tobin JR, Busija DW.
Glutamate-induced cerebral vasodilation is mediated by nitric oxide
through N-methyl-D-aspartate receptors.
Stroke. 1995;26:857-863.
29.
Kontos HA, Wei EP, Povlishock JT, Dietrich WD, Magrera
CJ, Ellis EF. Cerebral arteriolar damage by
arachidonic acid and prostaglandin
G2. Science. 1980;209:1242-1245.
30.
Kukreja RC, Kontos HA, Hess ML, Ellis EF. PGH
synthase and lipoxygenase generate superoxide in
the presence of NADH or NADPH. Circ Res. 1986;59:612-619.
This article has been cited by other articles:
![]() |
F. Domoki, B. Kis, K. Nagy, E. Farkas, D. W. Busija, and F. Bari Diazoxide preserves hypercapnia-induced arteriolar vasodilation after global cerebral ischemia in piglets Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H368 - H373. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Erdos, A. W. Miller, and D. W. Busija Alterations in KATP and KCa channel function in cerebral arteries of insulin-resistant rats Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2472 - H2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Lacza, M. Puskar, B. Kis, J. V. Perciaccante, A. W. Miller, and D. W. Busija Hydrogen peroxide acts as an EDHF in the piglet pial vasculature in response to bradykinin Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H406 - H411. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Marrelli, T. D. Johnson, A. Khorovets, W. F. Childres, R. M. Bryan Jr, and D. W. Busija Altered Function of Inward Rectifier Potassium Channels in Cerebrovascular Smooth Muscle After Ischemia/Reperfusion • Editorial Comment Stroke, July 1, 1998; 29(7): 1469 - 1474. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Armstead ATP-dependent K+ channel activation reduces loss of opioid dilation after brain injury Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1674 - H1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Veltkamp, F. Domoki, F. Bari, D. W. Busija, and W. G. Mayhan Potassium Channel Activators Protect the N-Methyl-D-Aspartate–Induced Cerebral Vascular Dilation After Combined Hypoxia and Ischemia in Piglets • Editorial Comment Stroke, April 1, 1998; 29(4): 837 - 843. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Bari, T. M. Louis, D. W. Busija, and W. J. Pearce Effects of Ischemia on Cerebral Arteriolar Dilation to Arterial Hypoxia in Piglets • Editorial Comment Stroke, January 1, 1998; 29(1): 222 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kasemsri and W. M. Armstead Endothelin impairs ATP-sensitive K+ channel function after brain injury Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2639 - H2647. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Armstead Brain Injury Impairs ATP-Sensitive K+ Channel Function in Piglet Cerebral Arteries Stroke, November 1, 1997; 28(11): 2273 - 2280. [Abstract] [Full Text] |
||||
![]() |
F. Bari, T. M. Louis, W. Meng, D. W. Busija, and W. G. Mayhan Global Ischemia Impairs ATP-Sensitive K+ Channel Function in Cerebral Arterioles in Piglets Stroke, October 1, 1996; 27(10): 1874 - 1881. [Abstract] [Full Text] |
||||
![]() |
F. Bari, R. A. Errico, T. M. Louis, D. W. Busija, and F. M. Faraci Differential Effects of Short-term Hypoxia and Hypercapnia on N-Methyl-D-Aspartate–Induced Cerebral Vasodilatation in Piglets Stroke, September 1, 1996; 27(9): 1634 - 1640. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |